Lifshitz & Miller LLP Announces Investigation of Bristow Group Inc., Helius Medical Technologies, Inc., Nordstrom Inc., PriceSmart, Inc., Ryanair Holdings plc, Solid Biosciences Inc., and Vanda Pharmaceuticals Inc.

Nordstrom Inc. (JWN)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the announcement of poor same store sales and that credit card holders were charged incorrect interest amounts.

If you are a Nordstrom investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

PriceSmart, Inc. (PSMT)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with management determining that the Company lacked adequate controls over the classification of certain financial instruments as cash equivalents or short-term investments.

If you are a PriceSmart investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Ryanair Holdings plc (RYAAY)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Ryanair's labor relations had deteriorated in 2017 and 2018, resulting in increased employee turnover, labor strikes, and other disruptions to its operations, which negatively impacted Ryanair's historical operating model and profit growth.

If you are a Ryanair investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Solid Biosciences Inc. (SLDB)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the announcement of efficacy issues with clinical trials for lead drug candidate SGT-001.

If you are a Solid Biosciences investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Vanda Pharmaceuticals Inc. (VNDA)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that "Vanda has engaged in a series of fraudulent schemes, some personally orchestrated by [its CEO], to defraud government payors."

If you are a Vanda investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2019 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-bristow-group-inc-helius-medical-technologies-inc-nordstrom-inc-pricesmart-inc-ryanair-holdings-plc-solid-biosciences-inc-and-vanda-pharmaceuticals-inc-300799154.html

SOURCE Lifshitz & Miller Law Firm